MedTrace Logo

A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy

NCT05583734 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-04-23

No results posted yet for this study

Summary

This is a self-controlled, prospective trial. The objective of this trial is to evaluate the efficacy and safety of the Portomar(TM) device for bone marrow biopsy.

Conditions

  • Hematologic Malignancy

Interventions

DEVICE

Portomar(TM) Device

Portomar(TM) access device for bone marrow biopsy

Sponsors & Collaborators

  • Aperture Medical Technology, LLC

    lead INDUSTRY

Principal Investigators

  • Rahul Sheth · MD Anderson

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-22
Primary Completion
2025-10-31
Completion
2025-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05583734 on ClinicalTrials.gov